APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis.

Saved in:
Bibliographic Details
Title: APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis.
Authors: Dźwigała M; Department and Clinic of Dermatology and Paediatric Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland., Sys D; Department of Translational Immunology and Functional Microbiota Research, Centre of Translational Research, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland., Życka-Krzesińska J; Department of Translational Immunology and Functional Microbiota Research, Centre of Translational Research, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland., Rybicka B; Department of Biochemistry and Molecular Biology, Centre of Translational Research, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland., Popławski P; Department of Biochemistry and Molecular Biology, Centre of Translational Research, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland., Walecka-Herniczek I; Department and Clinic of Dermatology and Paediatric Dermatology, Centre of Postgraduate Medical Education, 02-507 Warsaw, Poland., Piekiełko-Witkowska A; Department of Biochemistry and Molecular Biology, Centre of Translational Research, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland., Bogusławska J; Department of Translational Immunology and Functional Microbiota Research, Centre of Translational Research, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
Source: International journal of molecular sciences [Int J Mol Sci] 2026 Jun 26; Vol. 27 (13). Date of Electronic Publication: 2026 Jun 26.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first